diagnostics 2016 limited Company Information
Company Number
10048994
Next Accounts
Aug 2025
Shareholders
solingen private equity no 1 l.p.
michael beresford hadfield
Group Structure
View All
Industry
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Registered Address
oak house 317 golden hill lane, leyland, lancashire, PR25 2YJ
Website
www.biorexdiagnostics.comdiagnostics 2016 limited Estimated Valuation
Pomanda estimates the enterprise value of DIAGNOSTICS 2016 LIMITED at £0 based on a Turnover of £0 and 1.07x industry multiple (adjusted for size and gross margin).
diagnostics 2016 limited Estimated Valuation
Pomanda estimates the enterprise value of DIAGNOSTICS 2016 LIMITED at £10.5m based on an EBITDA of £2.4m and a 4.45x industry multiple (adjusted for size and gross margin).
diagnostics 2016 limited Estimated Valuation
Pomanda estimates the enterprise value of DIAGNOSTICS 2016 LIMITED at £1.4m based on Net Assets of £1m and 1.34x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Diagnostics 2016 Limited Overview
Diagnostics 2016 Limited is a live company located in lancashire, PR25 2YJ with a Companies House number of 10048994. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in March 2016, it's largest shareholder is solingen private equity no 1 l.p. with a 91.1% stake. Diagnostics 2016 Limited is a young, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Diagnostics 2016 Limited Health Check
There is insufficient data available to calculate a health check for Diagnostics 2016 Limited. Company Health Check FAQs


0 Strong

0 Regular

2 Weak

Size
There is insufficient data available for this Key Performance Indicator!
- - Diagnostics 2016 Limited
- - Industry AVG

Growth
There is insufficient data available for this Key Performance Indicator!
- Diagnostics 2016 Limited
- - Industry AVG

Production
There is insufficient data available for this Key Performance Indicator!
- Diagnostics 2016 Limited
- - Industry AVG

Profitability
There is insufficient data available for this Key Performance Indicator!
- Diagnostics 2016 Limited
- - Industry AVG

Employees
There is insufficient data available for this Key Performance Indicator!
- - Diagnostics 2016 Limited
- - Industry AVG

Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Diagnostics 2016 Limited
- - Industry AVG

Efficiency
There is insufficient data available for this Key Performance Indicator!
- Diagnostics 2016 Limited
- - Industry AVG

Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Diagnostics 2016 Limited
- - Industry AVG

Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Diagnostics 2016 Limited
- - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- Diagnostics 2016 Limited
- - Industry AVG

Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (14 weeks)
- - Diagnostics 2016 Limited
- - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 78.6%, this is a higher level of debt than the average (69%)
- - Diagnostics 2016 Limited
- - Industry AVG
DIAGNOSTICS 2016 LIMITED financials

Diagnostics 2016 Limited's latest turnover from November 2023 is estimated at 0 and the company has net assets of £1 million. According to their latest financial statements, we estimate that Diagnostics 2016 Limited has no employees and maintains cash reserves of £2.8 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
---|---|---|---|---|---|---|---|---|
Turnover | ||||||||
Other Income Or Grants | ||||||||
Cost Of Sales | ||||||||
Gross Profit | ||||||||
Admin Expenses | ||||||||
Operating Profit | ||||||||
Interest Payable | ||||||||
Interest Receivable | ||||||||
Pre-Tax Profit | ||||||||
Tax | ||||||||
Profit After Tax | ||||||||
Dividends Paid | ||||||||
Retained Profit | ||||||||
Employee Costs | ||||||||
Number Of Employees | ||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
---|---|---|---|---|---|---|---|---|
Tangible Assets | ||||||||
Intangible Assets | ||||||||
Investments & Other | 4,854,000 | 4,854,000 | 4,854,000 | 4,854,000 | 4,854,000 | 5,731,961 | 5,802,985 | 5,796,718 |
Debtors (Due After 1 year) | 108,180 | 71,641 | 32,300 | |||||
Total Fixed Assets | 4,854,000 | 4,854,000 | 4,854,000 | 4,854,000 | 4,854,000 | 5,840,141 | 5,874,626 | 5,829,018 |
Stock & work in progress | ||||||||
Trade Debtors | 108,180 | 108,180 | 108,180 | 108,180 | ||||
Group Debtors | 237,493 | |||||||
Misc Debtors | 64,633 | |||||||
Cash | 2,829 | 6,689 | 4,537 | 36,932 | 38,595 | 33,867 | 1,435 | 277 |
misc current assets | ||||||||
total current assets | 2,829 | 6,689 | 112,717 | 145,112 | 146,775 | 142,047 | 238,928 | 64,910 |
total assets | 4,856,829 | 4,860,689 | 4,966,717 | 4,999,112 | 5,000,775 | 5,982,188 | 6,113,554 | 5,893,928 |
Bank overdraft | 360,000 | 314,375 | 381,072 | |||||
Bank loan | 278,362 | 278,361 | 278,361 | 360,000 | 360,000 | |||
Trade Creditors | ||||||||
Group/Directors Accounts | 1,298,757 | 1,046,257 | 793,657 | 732,007 | 573,607 | 182,507 | 500,657 | |
other short term finances | ||||||||
hp & lease commitments | ||||||||
other current liabilities | 43,332 | 3,000 | 2,000 | 6,000 | 3,000 | 13,041 | 6,535 | |
total current liabilities | 1,620,451 | 1,327,618 | 1,074,018 | 1,098,007 | 936,607 | 555,548 | 320,910 | 881,729 |
loans | 165,889 | 432,993 | 695,900 | 853,784 | 1,080,000 | 1,440,000 | 1,174,151 | 1,421,829 |
hp & lease commitments | ||||||||
Accruals and Deferred Income | ||||||||
other liabilities | 2,030,568 | 4,179,030 | 3,858,808 | 3,424,066 | 3,102,770 | 2,920,100 | 3,192,947 | 2,919,873 |
provisions | ||||||||
total long term liabilities | 2,196,457 | 4,612,023 | 4,554,708 | 4,277,850 | 4,182,770 | 4,360,100 | 4,367,098 | 4,341,702 |
total liabilities | 3,816,908 | 5,939,641 | 5,628,726 | 5,375,857 | 5,119,377 | 4,915,648 | 4,688,008 | 5,223,431 |
net assets | 1,039,921 | -1,078,952 | -662,009 | -376,745 | -118,602 | 1,066,540 | 1,425,546 | 670,497 |
total shareholders funds | 1,039,921 | -1,078,952 | -662,009 | -376,745 | -118,602 | 1,066,540 | 1,425,546 | 670,497 |
Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||
Operating Profit | ||||||||
Depreciation | ||||||||
Amortisation | ||||||||
Tax | ||||||||
Stock | ||||||||
Debtors | -108,180 | -200,954 | 212,201 | 96,933 | ||||
Creditors | ||||||||
Accruals and Deferred Income | 40,332 | 1,000 | -4,000 | 3,000 | -10,041 | 6,506 | 6,535 | |
Deferred Taxes & Provisions | ||||||||
Cash flow from operations | ||||||||
Investing Activities | ||||||||
capital expenditure | ||||||||
Change in Investments | -877,961 | -71,024 | 6,267 | 5,796,718 | ||||
cash flow from investments | ||||||||
Financing Activities | ||||||||
Bank loans | 1 | -81,639 | 360,000 | |||||
Group/Directors Accounts | 252,500 | 252,600 | 61,650 | 158,400 | 391,100 | 182,507 | -500,657 | 500,657 |
Other Short Term Loans | ||||||||
Long term loans | -267,104 | -262,907 | -157,884 | -226,216 | -360,000 | 265,849 | -247,678 | 1,421,829 |
Hire Purchase and Lease Commitments | ||||||||
other long term liabilities | -2,148,462 | 320,222 | 434,742 | 321,296 | 182,670 | -272,847 | 273,074 | 2,919,873 |
share issue | ||||||||
interest | ||||||||
cash flow from financing | ||||||||
cash and cash equivalents | ||||||||
cash | -3,860 | 2,152 | -32,395 | -1,663 | 4,728 | 32,432 | 1,158 | 277 |
overdraft | -360,000 | 45,625 | -66,697 | 381,072 | ||||
change in cash | -3,860 | 2,152 | -32,395 | -1,663 | 364,728 | -13,193 | 67,855 | -380,795 |
diagnostics 2016 limited Credit Report and Business Information
Diagnostics 2016 Limited Competitor Analysis

Perform a competitor analysis for diagnostics 2016 limited by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other young companies, companies in PR25 area or any other competitors across 12 key performance metrics.
diagnostics 2016 limited Ownership
DIAGNOSTICS 2016 LIMITED group structure
Diagnostics 2016 Limited has 1 subsidiary company.
Ultimate parent company
1 parent
DIAGNOSTICS 2016 LIMITED
10048994
1 subsidiary
diagnostics 2016 limited directors
Diagnostics 2016 Limited currently has 4 directors. The longest serving directors include Mr Robin Womersley (Mar 2016) and Mr Paul Betts (Mar 2016).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Robin Womersley | England | 53 years | Mar 2016 | - | Director |
Mr Paul Betts | England | 49 years | Mar 2016 | - | Director |
Mr Michael Hadfield | England | 67 years | Mar 2016 | - | Director |
Ms Mary Bronserud | England | 51 years | Dec 2022 | - | Director |
P&L
November 2023turnover
0
0%
operating profit
2.4m
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
November 2023net assets
1m
-1.96%
total assets
4.9m
0%
cash
2.8k
-0.58%
net assets
Total assets minus all liabilities
diagnostics 2016 limited company details
company number
10048994
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
incorporation date
March 2016
age
9
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
November 2023
previous names
N/A
accountant
-
auditor
-
address
oak house 317 golden hill lane, leyland, lancashire, PR25 2YJ
Bank
-
Legal Advisor
-
diagnostics 2016 limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to diagnostics 2016 limited.
diagnostics 2016 limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DIAGNOSTICS 2016 LIMITED. This can take several minutes, an email will notify you when this has completed.
diagnostics 2016 limited Companies House Filings - See Documents
date | description | view/download |
---|